David Pook
Impact in
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Prostate Cancer Treatment and Research 33
- Renal cell carcinoma treatment 17
- Oncology 34
- Cancer Immunotherapy and Biomarkers 17
- Co-authors
- Gail P. Risbridger (13 shared papers)Renea A. Taylor (12 shared papers)Mark Frydenberg (13 shared papers)Roxanne Toivanen (5 shared papers)Mitchell G. Lawrence (7 shared papers)Hong Wang (3 shared papers)Stuart J. Ellem (3 shared papers)Melissa Papargiris (3 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)Annals of Oncology (11 papers)The Journal of Pathology (2 papers)European Urology (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
David Pook
52 papers receiving 962 citations
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 631
- Oncology 454
- Cancer Research 217
- Immunology 231
- Molecular Biology 309
Countries citing papers authored by David Pook
This map shows the geographic impact of David Pook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Pook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Pook more than expected).
Fields of papers citing papers by David Pook
This network shows the impact of papers produced by David Pook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Pook. The network helps show where David Pook may publish in the future.
Co-authors
The 25 scholars most cited alongside David Pook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 183 | |
| 2 | 2014 | 96 | |
| 3 | 2020 | 85 | |
| 4 | 2013 | 75 | |
| 5 | 2023 | 73 | |
| 6 | 2013 | 52 | |
| 7 | 2013 | 49 | |
| 8 | 2013 | 47 | |
| 9 | 2014 | 45 | |
| 10 | 2022 | 36 | |
| 11 | 2012 | 33 | |
| 12 | 2015 | 29 | |
| 13 | 2021 | 17 | |
| 14 | 2023 | 13 | |
| 15 | 2021 | 13 | |
| 16 | 2019 | 11 | |
| 17 | 2018 | 10 | |
| 18 | 2023 | 8 | |
| 19 | 2022 | 7 | |
| 20 | 2020 | 7 |
About David Pook
David Pook is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 60 papers that have together received 976 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (33 papers), Renal cell carcinoma treatment (17 papers), Cancer Immunotherapy and Biomarkers (17 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Renal and related cancers (7 papers), Cancer Genomics and Diagnostics (7 papers), Immunotherapy and Immune Responses (7 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (631 citations), Oncology (454 citations), Cancer Research (217 citations), Immunology (231 citations) and Molecular Biology (309 citations). David Pook has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Gail P. Risbridger, Renea A. Taylor, Mark Frydenberg, Roxanne Toivanen, Mitchell G. Lawrence, Hong Wang, Stuart J. Ellem, Melissa Papargiris, Birunthi Niranjan and Joan Carles. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Pathology, European Urology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.